Who is sponsoring NCT05632705?

NCT05632705 is sponsored by University of Pretoria.

What drugs are being tested in NCT05632705?

Interventions in NCT05632705: Closing pack.

What condition does NCT05632705 study?

NCT05632705 studies Prevention of Postpartum Sepsis.

Is NCT05632705 still recruiting?

NCT05632705 is currently completed. Last updated 30 November 2022.

Last reviewed 2022-11-30 · How we verify

NCT05632705

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Using a Closing Pack to Reduce Postpartum Sepsis

Completed NA Last updated 30 November 2022

What this trial tests

NA trial testing Closing pack in Prevention of Postpartum Sepsis in 1,000 participants. Completed in 30 April 2022.

Timeline

8 March 2021

Primary endpoint
31 January 2022

30 April 2022

Quick facts

Lead sponsor	University of Pretoria
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	1,000
Start date	8 March 2021
Primary completion	31 January 2022
Estimated completion	30 April 2022
Sites	1 location across South Africa

Drugs / interventions tested

Closing pack

Conditions studied

Prevention of Postpartum Sepsis — all drugs for Prevention of Postpartum Sepsis →

Sponsor

University of Pretoria

Who can join

18 and older, female only, with Prevention of Postpartum Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomised trial comparing the efficacy and feasibility of using a sterile closing pack to reduce postpartum sepsis

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Pretoria trials

Trials by the same sponsor.

NCT06982716 — Evaluating the Clinical Effectiveness of a Community-based Hearing Aid Fitting Service Delivery Model Facilitated by Com · NA · recruiting
NCT06487767 — The Validity of the Use of Imaging in Cervical Cancer Staging · not yet recruiting
NCT04792710 — Kefazolin Versus Kefazolin Plus Metronidazole to Reduce Postpartum Infection · Phase 4 · unknown
NCT02750202 — Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts · Phase 3 · completed
NCT04392362 — A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular · Phase 3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05632705 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pretoria
Last refreshed: 30 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05632705.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing